Clinical trial · Observational
Safe Infusion Device in Reducing Occupational Exposure of Nurses
Evaluation of a Safe Infusion Device in Reducing Occupational Exposure of Nurses to Antineoplastic Drugs: a Comparative Prospective Study. CONTAMOINS-1
NCT04102332CI-TRIAL-00040836CONTAMOINS-1completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Monocentric comparative before / after study to evaluate the efficacy of Safe Infusion Devices (SIDs) in reducing drug exposure to nurses compared to usual perfusion practices.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Safe Infusion Device | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Before arm
- description
- usual infusion practices (neutral solvent-purged infusers)
- label
- After arm
- description
- Safe Infusion Device
- interventionNames
- Device: Safe Infusion Device
Primary outcomes (1)
- measure
- Rate of contamination of nurses' gloves with cytotoxic products
- timeFrame
- day 1
- description
- The statistical unit consists of a sample taken from all the gloves used for the administration of a daily course. The dosing assay allowed to identify a panel of 10 cytotoxic drugs (HPLC MS/MS).
Secondary outcomes (3)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Protocols which contained at least one of the 10 drugs of the dosing assay * Protocols with at least one disconnection step. * Given the large number of eligible protocols, we favored those with the most concentrated products (CPM, PMX) to maximize the chance of detecting contamination and also to extend inclusions over a longer period. Exclusion Criteria: \- Drugs administrated with syringes (intravenously or subcutaneously) were not included because of the absence of impact of the SIDs on these modalities of administration.
References
Publications (0)
Data not yet available
No reference posted for this study.